Thao N D Pham
7PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 13, 2026
Resistance to the KRASG12D Inhibitor MRTX1133 Is Associated with Increased Sensitivity to BET Inhibition.Daniel R Principe, Jeffrey H Becker, Anastasia E Metropulos
|Aug 20, 2024
Trametinib Potentiates Anti-PD-1 Efficacy in Tumors Established from Chemotherapy-Primed Pancreatic Cancer Cells.Thao D Pham, Anastasia E Metropulos, Nida Mubin
|Aug 13, 2024
Targeting BCL2 with Venetoclax Enhances the Efficacy of the KRASG12D Inhibitor MRTX1133 in Pancreatic Cancer.Jeffrey H Becker, Anastasia E Metropulos, Christina Spaulding
|Jan 22, 2022
XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer.Daniel R Principe, Rui Xiong, Yangfeng Li
|Jan 28, 2021
Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies.Thao N D Pham, Mario A Shields, Christina Spaulding
|Aug 01, 2020
Controlling TIME: How MNK Kinases Function to Shape Tumor Immunity.Thao N D Pham, Christina Spaulding, Hidayatullah G Munshi
Pageof 2
Frequent Collaborators
4 joint publications
Daniel R Principe
3 joint publications
Jeffrey H Becker
3 joint publications
Anastasia E Metropulos
3 joint publications
Hidayatullah G Munshi
2 joint publications
Christina Spaulding
2 joint publications
Alejandra M Marinelarena
2 joint publications
Mario A Shields
1 joint publications
Nida Mubin
1 joint publications
Dhavan Shah
1 joint publications
David J Bentrem
